Related Experiment Videos
Essential hypertension and histocompatibility antigens. An association study
M Gerbase-DeLima1, M A Ladalardo, J J DeLima
1Escola Paulista de Medicina, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brazil.
Hypertension (Dallas, Tex. : 1979)
|April 1, 1992
Summary
Human Leukocyte Antigen (HLA)-DR4 may indicate a genetic susceptibility to essential hypertension in Brazilian Caucasians. This finding suggests HLA-DR4 could serve as a population-level marker for hypertension risk.
Area of Science:
- Immunogenetics
- Cardiovascular Disease Research
Background:
- Previous studies suggest genes linked to essential hypertension susceptibility are near the Human Leukocyte Antigen (HLA) complex.
- Investigating specific HLA genes as population-level markers for essential hypertension is warranted.
Purpose of the Study:
- To determine if specific HLA-A, HLA-B, or HLA-DR genes act as population-level markers for essential hypertension susceptibility.
- To analyze the frequency of HLA antigens in Caucasian essential hypertension patients and controls.
Main Methods:
- Determined HLA antigen frequencies in 89 Caucasian essential hypertension patients.
- Performed HLA-DR typing on 85 of the hypertensive patients.
- Compared HLA antigen frequencies with ethnically matched control subjects.
Main Results:
- An increased frequency of HLA-DR4 was observed in essential hypertension patients (34%) compared to controls (16%).
- The difference in HLA-DR4 frequency was statistically significant (p = 0.00064).
Conclusions:
- HLA-DR4 may serve as a marker for essential hypertension susceptibility within the Brazilian Caucasian population.
- These findings contribute to understanding the genetic basis of essential hypertension.